[1] |
Hyysalo J, Männistö VT, Zhou Y, et al. A population-based study on the prevalence of NASH using scores validated against liver histology. J Hepatol, 2014; 60, 839−46. doi: 10.1016/j.jhep.2013.12.009 |
[2] |
Kabarra K, Golabi P, Younossi ZM. Nonalcoholic steatohepatitis: global impact and clinical consequences. Endocr Connect, 2021; 10, R240−7. doi: 10.1530/EC-21-0048 |
[3] |
Zhou JH, Zhou F, Wang WX, et al. Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology, 2020; 71, 1851−64. doi: 10.1002/hep.31150 |
[4] |
Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut, 2010; 59, 1410−5. doi: 10.1136/gut.2010.213553 |
[5] |
Niriella MA, Pathmeswaran A, De Silva ST, et al. Incidence and risk factors for non-alcoholic fatty liver disease: a 7-year follow-up study among urban, adult Sri Lankans. Liver Int, 2017; 37, 1715−22. doi: 10.1111/liv.13478 |
[6] |
Jarvis H, Craig D, Barker R, et al. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies. PLoS Med, 2020; 17, e1003100. doi: 10.1371/journal.pmed.1003100 |
[7] |
Ko YH, Wong TC, Hsu YY, et al. The correlation between body fat, visceral fat, and nonalcoholic fatty liver disease. Metab Syndr Relat Disord, 2017; 15, 304−11. doi: 10.1089/met.2017.0001 |
[8] |
Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology, 2003; 124, 71−9. doi: 10.1053/gast.2003.50004 |
[9] |
Praveenraj P, Gomes RM, Kumar S, et al. Prevalence and predictors of non-alcoholic fatty liver disease in morbidly obese south Indian patients undergoing bariatric surgery. Obes Surg, 2015; 25, 2078−87. doi: 10.1007/s11695-015-1655-1 |
[10] |
Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol, 2006; 101, 76−82. doi: 10.1111/j.1572-0241.2005.00341.x |